Bozbulut, U. B. Et Al. 2024. Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study. Journal of Clinical Medicine , vol.13, no.3 .

Bozbulut, U. B., Cengiz, T., & ÖZET, A., (2024). Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study. Journal of Clinical Medicine , vol.13, no.3.

Bozbulut, Utku, Tuğba Cengiz, And AHMET ÖZET. "Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study," Journal of Clinical Medicine , vol.13, no.3, 2024

Bozbulut, Utku B. Et Al. "Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study." Journal of Clinical Medicine , vol.13, no.3, 2024

Bozbulut, U. B. Cengiz, T. And ÖZET, A. (2024) . "Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study." Journal of Clinical Medicine , vol.13, no.3.

@article{article, author={Utku Burak Bozbulut Et Al. }, title={Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study}, journal={Journal of Clinical Medicine}, year=2024}